European Society of Cardiology Congress 2016

European Society of Cardiology Congress 2016 | ESC 2016

Billed as "the world's largest and most influential cardiovascular congress," ESC 2016 will feature new conference tracks on surgery, stroke, and e-cardiology; new evidence and recommendations from clinical practice guidelines; and novel clinical trial results.

Conference Coverages

Pope Francis Visit Delights Docs at ESC Meeting
Pope Francis Visit Delights Docs at ESC Meeting
Thousands of cardiologists and other attendees at the ESC Congress 2016 got to meet Pope Francis, who told them he marveled at the science and human mystery of the heart.
Ibrahim Danad, MD: PACIFIC Trial: Which Imaging Tool Has The Greatest Diagnostic Accuracy? VIDEO
At The European Society of Cardiology Congress 2016 (ESC), Ibrahim Danad, MD, VU University Medical Center, Amsterdam, Netherlands, explained the results from his team's PACIFIC trial, which assessed two non-invasive coronary artery imaging tools: positon emission tomography (PET) and single photon emission computed tomography (SPECT).
PCI: New Imaging Detects Heart Attack Patients Who Don't Need It
About a quarter of patients who survived heart attacks due to blocked arteries could be treated with drugs, not invasive procedures. The trick is determining whether the blockage is cause by plaque erosion, not plaque rupture. With optical coherence tomography a team in Boston did just that.
Anselm K. Gitt, MD: DYSIS and Increased Persistent Lipid Abnormalities VIDEO
At the European Society of Cardiology Congress 2016 (ESC) in Rome, Italy, Anselm Gitt, MD discussed the DYSIS program, which was designed to get an idea to see how patients were treated for secondary prevention, focusing on dyslipidemia patients.
Two Antiplatelets Equal in Head-to-Head Trial
The antiplatelet drugs prasugrel and ticagrelor are both fine for dual antiplatelet therapy following acute myocardial infarctions with ST segment elevations, a Czech study found.
Study: Drug-Eluting Stents No Better than Bare Metal
Drug-eluting stents are falling far short of their promises of fewer complications, improved mortality and quality of life, a study found. In the largest study ever done comparing newer drug-eluting stents to bare metal devices, Norwegian researchers found the drug stents did not show a difference in these outcomes.
Chris Cannon, MD: New Dyslipidemia Guidelines & Global Health Implications VIDEO
At the European Society of Cardiology Congress 2016 (ESC) in Rome, Italy, Chris Cannon, MD, Brigham & Women's Hospital, discussed the latest changes with the dyslipidemia guidelines.
Victor Sandor, MD: ARRY 797 As a Specific Therapy for Dilated Cardiomyopathy? VIDEO
Victor Sandor, MD, Array BioPharma, shared results from ARRY 797 study at the European Society of Cardiology Congress 2016.
Cardiac Rehab: What Works, and for How Long
Should cardiac rehab be standard for patients who've had a heart attack. If so, how long should it last? A Dutch study found a year was about right.

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$